These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29594021)

  • 1. Men with a susceptibility to prostate cancer and the role of genetic based screening.
    Eeles R; Ni Raghallaigh H
    Transl Androl Urol; 2018 Feb; 7(1):61-69. PubMed ID: 29594021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer.
    Castro E; Mikropoulos C; Bancroft EK; Dadaev T; Goh C; Taylor N; Saunders E; Borley N; Keating D; Page EC; Saya S; Hazell S; Livni N; deSouza N; Neal D; Hamdy FC; Kumar P; Antoniou AC; Kote-Jarai Z; ; Eeles RA
    Oncologist; 2016 Jun; 21(6):716-22. PubMed ID: 27151655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of prostate cancer and its utility in treatment and screening.
    Benafif S; Ni Raghallaigh H; McHugh J; Eeles R
    Adv Genet; 2021; 108():147-199. PubMed ID: 34844712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
    JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer risk in men of differing genetic ancestry and approaches to disease screening and management in these groups.
    McHugh J; Saunders EJ; Dadaev T; McGrowder E; Bancroft E; Kote-Jarai Z; Eeles R
    Br J Cancer; 2022 Jun; 126(10):1366-1373. PubMed ID: 34923574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic predisposition to prostate cancer.
    Benafif S; Eeles R
    Br Med Bull; 2016 Dec; 120(1):75-89. PubMed ID: 27941040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
    Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H;
    Lancet Oncol; 2021 Sep; 22(9):1240-1249. PubMed ID: 34391509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic predisposition to prostate cancer: an update.
    Ni Raghallaigh H; Eeles R
    Fam Cancer; 2022 Jan; 21(1):101-114. PubMed ID: 33486571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates in Prostate Cancer Research and Screening in Men at Genetically Higher Risk.
    Bancroft EK; Raghallaigh HN; Page EC; Eeles RA
    Curr Genet Med Rep; 2021; 9(4):47-58. PubMed ID: 34790437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adenocarcinoma of the prostate].
    Dvorácek J
    Cas Lek Cesk; 1998 Aug; 137(17):515-21. PubMed ID: 9787503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.
    Drake BF; Keane TE; Mosley CM; Adams SA; Elder KT; Modayil MV; Ureda JR; Hebert JR
    J S C Med Assoc; 2006 Aug; 102(7):241-9. PubMed ID: 17319238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate Cancer Screening in a New Era of Genetics.
    Cheng HH; Pritchard CC; Montgomery B; Lin DW; Nelson PS
    Clin Genitourin Cancer; 2017 Dec; 15(6):625-628. PubMed ID: 28697982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial.
    Chen H; Liu X; Brendler CB; Ankerst DP; Leach RJ; Goodman PJ; Lucia MS; Tangen CM; Wang L; Hsu FC; Sun J; Kader AK; Isaacs WB; Helfand BT; Zheng SL; Thompson IM; Platz EA; Xu J
    Prostate; 2016 Sep; 76(12):1120-9. PubMed ID: 27197965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer screening in BRCA and Lynch syndrome mutation carriers.
    Castro E; Goh CL; Eeles RA
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities.
    Tan SH; Petrovics G; Srivastava S
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29690565
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.